Synaptophysin and GAP-43 mRNA levels in the hippocampus of subjects with schizophrenia

Schizophrenia Research
M J WebsterJ E Kleinman

Abstract

Synaptophysin and growth associated protein-43 (GAP-43) are synaptic proteins colocalized to the presynaptic terminal, and involved in regulating transmitter release and synaptic plasticity. Recent studies have proposed an alteration in the number of synapses in the brains of individuals with schizophrenia. As a corollary, we hypothesized that there may be an alteration in the level of mRNAs that code for synaptic proteins in brains of patients with schizophrenia. Using in situ hybridization, we investigated the levels of synaptophysin and GAP-43 mRNA in the medial temporal lobe of 10 normal subjects, 11 subjects with schizophrenia and 10 psychiatric control subjects. Synaptophysin mRNA levels were significantly reduced in several hippocampal subfields in both the schizophrenic and psychiatric control groups. GAP-43 mRNA levels were not significantly reduced in either group. The implications of these findings are discussed in relation to neuroleptic treatment and the pathophysiology of mental illness.

References

Dec 1, 1991·The British Journal of Psychiatry : the Journal of Mental Science·J Collinge, D Curtis
Jun 1, 1990·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·E MasliahR DeTeresa
Mar 1, 1989·Neurology·J E HamosD A Drachman
May 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·R L NeveL I Benowitz
Jun 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·R JahnP Greengard
May 1, 1995·The Journal of Comparative Neurology·R InsaustiL M Gonzalo
Jan 1, 1995·Molecular and Chemical Neuropathology·A C SowerN I Perrone-Bizzozero
Feb 1, 1993·Journal of Neurochemistry·K J IvinsR L Neve
Jan 22, 1993·The Journal of Comparative Neurology·R H MelloniL J DeGennaro
Dec 28, 1995·Brain Research. Molecular Brain Research·P J MebergA Routtenberg
Nov 26, 1996·Proceedings of the National Academy of Sciences of the United States of America·N I Perrone-BizzozeroR L Neve
Feb 1, 1997·Trends in Neurosciences·L I Benowitz, A Routtenberg
Jan 4, 1998·Cerebral Cortex·L S KrimerD R Weinberger
Jun 9, 1998·Cerebral Cortex·C E YoungW G Honer

❮ Previous
Next ❯

Citations

Sep 23, 2003·Brain Research. Brain Research Reviews·Michael S Lidow
Apr 15, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Peter M ThompsonMarquis P Vawter
Sep 27, 2003·Schizophrenia Research·Paul J HarrisonJohn R Geddes
Jul 11, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Amanda J LawPaul J Harrison
Oct 1, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Eva HradetzkySabine Bahn
Jun 16, 2011·PloS One·Kazuo YamadaTakeo Yoshikawa
Oct 27, 2007·Schizophrenia Research·Cynthia Shannon WeickertRichard E Straub
Feb 8, 2005·Progress in Neuro-psychopharmacology & Biological Psychiatry·Jessie S ChambersNora I Perrone-Bizzozero
Aug 13, 2004·Brain Research. Molecular Brain Research·Jorge E Torres-MuñozCarol K Petito
Feb 5, 2005·Biological Psychiatry·E Fuller TorreyMichael B Knable
Feb 22, 2012·Schizophrenia Research·Yu-Chih ShenChia-Hsiang Chen
Sep 12, 2002·Expert Opinion on Therapeutic Targets·Outi Kontkanen, Eero Castrén
Apr 7, 2015·Brain, Behavior, and Immunity·Amy R Wolff, David K Bilkey
Jun 9, 2009·Schizophrenia Research·Gursharan ChanaIan Everall
Oct 20, 2006·Journal of Psychopharmacology·Sharon L EastwoodPaul J Harrison
Oct 16, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Subroto GhoseJoel E Kleinman
Feb 24, 2018·Journal of Toxicology and Environmental Health. Part a·Seulah LeeJaewon Lee
Jan 29, 2021·Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology·Rituparna MaitiSantanu Nath

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here